The expression of CD39 on circulating Sezary cells is genetically controlled

被引：0
|
作者：
Picozza, M. [1 ]
Caprini, E. [2 ]
Cristofoletti, C. [2 ]
Bresin, A. [2 ]
Monopoli, A. [2 ]
Borsellino, G. [1 ]
Russo, G. [2 ]
Narducci, M. G. [2 ]
机构：
[1] Fdn Santa Lucia, Lab Neuroimmunol, I-00143 Rome, Italy
[2] IRCCS, IDI, Lab Mol Oncol, I-00167 Rome, Italy
来源：
EUROPEAN JOURNAL OF CANCER | 2019年 / 119卷
关键词：
D O I：
10.1016/S0959-8049(19)30629-X
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
119
引用
收藏
页码：S43 / S43
页数：1
相关论文
共 50 条
  • [1] CD39 Expression in Mesenchymal Stromal Cells
    Saldanha-Araujo, Felipe
    Panepucci, Rodrigo A.
    JOURNAL OF IMMUNOTHERAPY, 2011, 34 (07) : 568 - 568
  • [2] The expression of CD39 on regulatory T cells is genetically driven and further upregulated at sites of inflammation
    Rissiek, Anne
    Baumann, Isabell
    Cuapio, Angelica
    Mautner, Andrea
    Kolster, Manuela
    Arck, Petra C.
    Dodge-Khatami, Ali
    Mittruecker, Hans-Willi
    Koch-Nolte, Friedrich
    Haag, Friedrich
    Tolosa, Eva
    JOURNAL OF AUTOIMMUNITY, 2015, 58 : 12 - 20
  • [3] Identification of CD39 as a Marker for the Circulating Malignant T-Cell Clone of Sezary Syndrome Patients
    Bensussan, Armand
    Janela, Baptiste
    Thonnart, Nicolas
    Bagot, Martine
    Musette, Philippe
    Ginhoux, Florent
    Marie-Cardine, Anne
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2019, 139 (03) : 725 - 728
  • [4] Regulatory T cells and CD39 expression in transplantation
    Dwyer, Karen
    Robson, Simon
    PURINERGIC SIGNALLING, 2010, 6 : 26 - 26
  • [5] Effects of Mogamulizumab on CD39, CD73 and CD38 ectonucleotidases expression in T-cells of Sezary syndrome patients
    Roccuzzo, G.
    Yakymiv, Y.
    Marchisio, S.
    Ortolan, E.
    Lin, L.
    Marega, L.
    Fava, P.
    Ponti, R.
    Senetta, R.
    Ribero, S.
    Funaro, A.
    Quaglino, P.
    EUROPEAN JOURNAL OF CANCER, 2024, 211 : S4 - S5
  • [6] Resident cardiac immune cells and expression of CD39 and CD73
    Borg, N.
    Boenner, F.
    Bongardt, S.
    Schrader, J.
    PURINERGIC SIGNALLING, 2012, 8 (01) : 161 - 162
  • [7] Genetically Driven CD39 Expression Affects Sezary Cell Viability and IL-2 Production and Detects Two Patient Subsets with Distinct Prognosis
    Picozza, Mario
    Cristofoletti, Cristina
    Bresin, Antonella
    Fioretti, Martina
    Sambucci, Manolo
    Scala, Enrico
    Monopoli, Alessandro
    Cantonetti, Maria
    Pilla, Maria Antonietta
    Accetturi, Maria Pina
    Borsellino, Giovanna
    D'Atri, Stefania
    Caprini, Elisabetta
    Russo, Giandomenico
    Narducci, Maria Grazia
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2022, 142 (11) : 3009 - +
  • [8] High glucose enhances CD39 expression in vascular endothelial cells
    Kongkhum, Sudawadee
    Fungkrajai, Mudtika
    Prajan, Sompoch
    Bordeerat, Narisa Kengtrong
    Piumngam, Kanyanath
    Siripurkpong, Pilaiwan
    ASIAN BIOMEDICINE, 2014, 8 (02) : 283 - 287
  • [9] TREG CELLS IN CLL: DEFECTIVE FUNCTION AND HIGH CD39 EXPRESSION
    Mehtap, O.
    Gacar, G.
    Aksoy, A.
    Atesoglu, E. Birtas
    Tarkun, P.
    Erman, G.
    Can, B.
    Hacihanefioglu, A.
    Karaoz, E.
    HAEMATOLOGICA, 2015, 100 : 413 - 414
  • [10] CD39 Expression Identifies Terminally Exhausted CD8+ T Cells
    Gupta, Prakash K.
    Godec, Jernej
    Wolski, David
    Adland, Emily
    Yates, Kathleen
    Pauken, Kristen E.
    Cosgrove, Cormac
    Ledderose, Carola
    Junger, Wolfgang G.
    Robson, Simon C.
    Wherry, E. John
    Alter, Galit
    Goulder, Philip J. R.
    Klenerman, Paul
    Sharpe, Arlene H.
    Lauer, Georg M.
    Haining, W. Nicholas
    PLoS Pathogens, 2015, 11 (10)
12345